Ad

Apr 30, 2026

🌡️–

#Pharmaceuticals

Merck Surpasses Q1 Expectations Driven by Keytruda and Emerging Drugs, Tightens 2026 Forecast
Photo credits: CNBC

Merck Surpasses Q1 Expectations Driven by Keytruda and Emerging Drugs, Tightens 2026 Forecast

Strong sales of cancer drug Keytruda and new therapies boost Merck's outlook despite quarterly loss

Finance
Eli Lilly Surges Past Q1 Expectations, Boosts 2026 Outlook on Soaring Zepbound and Mounjaro Sales
Photo credits: CNBC

Eli Lilly Surges Past Q1 Expectations, Boosts 2026 Outlook on Soaring Zepbound and Mounjaro Sales

Pharma giant Eli Lilly raises full-year revenue and profit forecasts amid strong demand for weight loss and diabetes drugs.

Finance

Ad